The search for an effective treatment for critical limb ischemia continues
Despite showing promising results in a recent phase 2 trial, administration of a novel gene therapy (NV1FGF) to enhance the growth of new blood vessels in people with critical limb ischaemia (whose legs are damaged when blocked ...
May 30, 2011
0
0